What is Eculizumab?

Category: Prescription Drugs

Most popular types: Soliris


Eculizumab is a monoclonal antibody used to reduce hemolysis in the treatment of paroxysmal nocturnal hemoglobinuria, a rare, acquired, potentially life-threatening disease of the blood characterised by complement-induced hemolytic anemia.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Eculizumab

Side effect Patients
Elevated blood pressure 1


Based on patients currently taking Eculizumab

Dosage Patients
300 mg/30ml every other week 1


Currently taking Eculizumab

Duration Patients
5 - 10 years 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Eculizumab.